TY - JOUR
T1 - Effects of acute cytomegalovirus infection on rat islet allograft survival
AU - Smelt, M J
AU - de Haan, B J
AU - Faas, M M
AU - Melgert, B N
AU - de Haan, A
AU - de Vos, P
PY - 2011/9/1
Y1 - 2011/9/1
N2 - Transplantation of pancreatic islets is a promising therapy for the treatment of type 1 diabetes mellitus. However, long-term islet graft survival rates are still unsatisfactory low. In this study we investigated the role of cytomegalovirus (CMV) in islet allograft failure. STZ-diabetic rats received an allogenic islet graft in combination with either an acute CMV infection or control infection. A third group received ganciclovir treatment in addition to the CMV infection. Graft function was assessed by measuring basal blood glucose levels. After sacrifice, the islet grafts were retrieved for analysis of infection and leukocyte infiltration. CMV-infected recipients demonstrated accelerated islet graft failure compared to noninfected controls. CMV infection of the graft was only observed prior to complete graft failure. Quantification of the leukocyte infiltration demonstrated increased CD8+ T-cell and NK cell infiltration in the CMV-infected grafts compared to the controls. This suggests that CMV infection accelerates immune-mediated graft destruction. Antiviral ganciclovir treatment did not prevent accelerated graft failure, despite effectively decreasing the grade of infection. Our data confirm the recently published CITR data, which state that CMV is an independent risk factor for failure of islet grafts. Also, our data demonstrate that new approaches for preventing virus-induced islet allograft failure may be required. © 2011 Cognizant Comm. Corp.
AB - Transplantation of pancreatic islets is a promising therapy for the treatment of type 1 diabetes mellitus. However, long-term islet graft survival rates are still unsatisfactory low. In this study we investigated the role of cytomegalovirus (CMV) in islet allograft failure. STZ-diabetic rats received an allogenic islet graft in combination with either an acute CMV infection or control infection. A third group received ganciclovir treatment in addition to the CMV infection. Graft function was assessed by measuring basal blood glucose levels. After sacrifice, the islet grafts were retrieved for analysis of infection and leukocyte infiltration. CMV-infected recipients demonstrated accelerated islet graft failure compared to noninfected controls. CMV infection of the graft was only observed prior to complete graft failure. Quantification of the leukocyte infiltration demonstrated increased CD8+ T-cell and NK cell infiltration in the CMV-infected grafts compared to the controls. This suggests that CMV infection accelerates immune-mediated graft destruction. Antiviral ganciclovir treatment did not prevent accelerated graft failure, despite effectively decreasing the grade of infection. Our data confirm the recently published CITR data, which state that CMV is an independent risk factor for failure of islet grafts. Also, our data demonstrate that new approaches for preventing virus-induced islet allograft failure may be required. © 2011 Cognizant Comm. Corp.
KW - Animals
KW - Antiviral Agents/pharmacology
KW - Blood Glucose/drug effects
KW - Cell Movement/drug effects
KW - Cytomegalovirus/drug effects
KW - Cytomegalovirus Infections/immunology
KW - Ganciclovir/pharmacology
KW - Graft Survival/drug effects
KW - Immunity/drug effects
KW - Islets of Langerhans Transplantation/immunology
KW - Rats
KW - Rats, Inbred Lew
KW - Salivary Glands/drug effects
KW - Transplantation, Homologous
UR - http://www.mendeley.com/research/effects-acute-cytomegalovirus-infection-rat-islet-allograft-survival
U2 - 10.3727/096368910X545077
DO - 10.3727/096368910X545077
M3 - Article
C2 - 21176406
SN - 0963-6897
VL - 20
SP - 1271
EP - 1283
JO - Cell Transplantation
JF - Cell Transplantation
IS - 8
ER -